Steplewski; Zenon
Patent Applications and Registrations
Patent applications and USPTO patent grants for Steplewski; Zenon.The latest application filed is for "monoclonal antibodies against glycolipid antigens, methods of producing these antibodies, and use therefor".
- Steplewski; Zenon - Malvern PA
- Steplewski; Zenon - Strafford PA
| Patent | Date |
|---|---|
| Monoclonal antibodies against glycolipid antigens, methods of producing these antibodies, and use therefor Grant 5,182,192 - Steplewski , et al. January 26, 1 | 1993-01-26 |
| Radiotherapeutic immunoconjugates labeled with iodine-125 Grant 5,130,116 - Woo , et al. July 14, 1 | 1992-07-14 |
| Monoclonal antibodies against melanoma-associated antigens and hybrid cell lines producing these antibodies Grant 4,849,509 - Thurin , et al. July 18, 1 | 1989-07-18 |
| Lewis blood group phenotype assay Grant 4,607,009 - Steplewski , et al. August 19, 1 | 1986-08-19 |
| Detection of colorectal carcinoma Grant 4,471,057 - Koprowski , et al. September 11, 1 | 1984-09-11 |
| Monocolonal hybridoma antibody specific for high molecular weight carcinoembryonic antigen Grant 4,349,528 - Koprowski , et al. September 14, 1 | 1982-09-14 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 